EDGAR Filing Documents for 0001193125-17-203545

Form 8-K - Current report:

SEC Accession No. 0001193125-17-203545

Filing Date

2017-06-14

Accepted

2017-06-14 16:35:33

Documents

Period of Report

2017-06-12

Items

Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	d410855d8k.htm	8-K	31943
2	EX-10.1	d410855dex101.htm	EX-10.1	8933
3	EX-10.2	d410855dex102.htm	EX-10.2	10938
	Complete submission text file	0001193125-17-203545.txt		53237

Mailing Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024

Business Address 10880 WILSHIRE BLVD. SUITE 2150 LOS ANGELES CA 90024 (424) 248-6500

PUMA BIOTECHNOLOGY, INC. (Filer) CIK: 0001401667 (see all company filings)